Skip to main content

Table 2 Human diseases in which VIP has been shown to have therapeutic potential

From: Transcriptional modulation by VIP: a rational target against inflammatory disease

Disease

Reference

Alzheimer’s disease

Gozes et al. (1996)

Asthma

Morice and Sever (1986)

Diabetes

Herrera et al. (2006)

Inflammatory bowel disease

Abad et al. (2003, 2005)

Graft versus host disease

Chorny et al. (2006)

Pancreatitis

Kojima et al. (2005)

Parkinson’s disease

Korkmaz et al. (2010)

Rheumatoid arthritis

Delgado et al. (2001)

Sepsis

Chorny and Delgado (2008); Delgado et al. (1999c)

Uveoretinitis

Keino et al. (2004)

  1. Studies using rodent models and, in some cases, human clinical trials are shown with relevant references